LayerRx Mapping ID
115
Slot System
Featured Buckets
Featured Buckets Admin
Medscape Lead Concept
5000574

Expert's Mohs Tips Based on Review of Slides

Article Type
Changed
Display Headline
Expert's Mohs Tips Based on Review of Slides

SANTA ANA PUEBLO, N.M. — Evaluation of Mohs specimens sent to the American Society for Mohs Surgery for peer review has offered an opportunity to critique various styles of processing Mohs specimens and of planning second stages.

Some styles fail to comply with the basic principle of Mohs surgery. Undermining-type stage II reexcisions, straight-down cuts through the midline of stage II, and squared-off edges are examples of types of stage II reexcisions "that can turn the Mohs proof of tumor extirpation to pretense," Dr. Sharon F. Tiefenbrunn said at a meeting of the American Society for Mohs Surgery (ASMS).

Mohs surgery "is a proven technique with a 95%–99% cure rate in the published literature," she said, but the rules "used to plan reexcision and to evaluate adequacy of the slides from these reexcisions have not been published."

She discussed her "rules" for Mohs surgery based on patterns that emerged during the analysis. "Most of these rules are fairly obvious and are stated for completeness," said Dr. Tiefenbrunn, a dermatologic surgeon who practices in St. Louis and is the current president of the ASMS.

Rules for stage I include the following:

▸ The complete skin edge must be included on the slides and examined. (The ASMS uses 90% as its standard of completeness.)

▸ The complete deep margin (90%) must be present on the slide.

▸ Make sure tissue remains intact on the wafers, without shredding.

▸ Make sure structural details are visible.

▸ Use adequate stain.

▸ Use visible ink for orientation and to ensure complete examination of sectioned specimens.

▸ Tumor must be identified and mapped accurately.

The rules for stage II include:

▸ If the skin edge is missing on stage I, it must be taken on stage II.

▸ If deep tissue is missing on stage I, it must be taken on stage II. "We see a few cases where these simple mandates slide by," she said.

▸ Stage II must include the tumor in stage I. "Early wafers must be unequivocally clear to call the stage clear if tumor is seen deep in the block," she said.

▸ Respect the Heisenberg uncertainty principle. "We must overlap in all directions from the edge of the tumor and we must connect to the previous layer and confirm with inked margins," said Dr. Tiefenbrunn.

If the connection to the defect left by the previous stage is not examined, a larger overlap will be needed.

She pointed out that taking 20 turns of the cryostat before putting a section on the slide means that approximately 200 micrometers of tissue from the sample are lost. This amounts to 0.2 mm, a space in which tumor can travel undetected. If 95% of all possible angles of spread of the tumor are to be examined, an overlap of about 2.5 mm is needed.

"Failure to follow the above rules can turn proof to pretense," she said.

Common errors in Mohs surgery occur in planning the second stage, particularly inadequate overlap and lack of concern about observing the line of connection of stage II to stage I. "Undermining-type reexcisions in which the dermal rim of tissue is undermined and a vertical or beveled incision is made circumferentially around the defect connecting to this plane, frequently accompanied by vertical incision extending radially from the defect to complete this excision, [are] a common error," she said.

"This section is then processed so that only one of the four planes of the surgical margin is examined. The exclusion of the deep margin and the radially cut ends of the specimen from exam can allow tumor to be left behind. Proper process of an undermining stage II is difficult for the technician. Even if this type of reexcision is processed properly, there is inadequate overlap on the deep margin," she said.

"Straight-down cuts, such as the type made when stage II is reexcising half of the stage I defect, are another source of error," she said. "If a straight-down cut is used and not adequately flattened, this 2.5 mm of necessary overlap doubles the every-0.2 mm of space between the defect and the depth of the reexcision. This needed overlap can easily exceed the size of the defect."

Article PDF
Author and Disclosure Information

Publications
Topics
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

SANTA ANA PUEBLO, N.M. — Evaluation of Mohs specimens sent to the American Society for Mohs Surgery for peer review has offered an opportunity to critique various styles of processing Mohs specimens and of planning second stages.

Some styles fail to comply with the basic principle of Mohs surgery. Undermining-type stage II reexcisions, straight-down cuts through the midline of stage II, and squared-off edges are examples of types of stage II reexcisions "that can turn the Mohs proof of tumor extirpation to pretense," Dr. Sharon F. Tiefenbrunn said at a meeting of the American Society for Mohs Surgery (ASMS).

Mohs surgery "is a proven technique with a 95%–99% cure rate in the published literature," she said, but the rules "used to plan reexcision and to evaluate adequacy of the slides from these reexcisions have not been published."

She discussed her "rules" for Mohs surgery based on patterns that emerged during the analysis. "Most of these rules are fairly obvious and are stated for completeness," said Dr. Tiefenbrunn, a dermatologic surgeon who practices in St. Louis and is the current president of the ASMS.

Rules for stage I include the following:

▸ The complete skin edge must be included on the slides and examined. (The ASMS uses 90% as its standard of completeness.)

▸ The complete deep margin (90%) must be present on the slide.

▸ Make sure tissue remains intact on the wafers, without shredding.

▸ Make sure structural details are visible.

▸ Use adequate stain.

▸ Use visible ink for orientation and to ensure complete examination of sectioned specimens.

▸ Tumor must be identified and mapped accurately.

The rules for stage II include:

▸ If the skin edge is missing on stage I, it must be taken on stage II.

▸ If deep tissue is missing on stage I, it must be taken on stage II. "We see a few cases where these simple mandates slide by," she said.

▸ Stage II must include the tumor in stage I. "Early wafers must be unequivocally clear to call the stage clear if tumor is seen deep in the block," she said.

▸ Respect the Heisenberg uncertainty principle. "We must overlap in all directions from the edge of the tumor and we must connect to the previous layer and confirm with inked margins," said Dr. Tiefenbrunn.

If the connection to the defect left by the previous stage is not examined, a larger overlap will be needed.

She pointed out that taking 20 turns of the cryostat before putting a section on the slide means that approximately 200 micrometers of tissue from the sample are lost. This amounts to 0.2 mm, a space in which tumor can travel undetected. If 95% of all possible angles of spread of the tumor are to be examined, an overlap of about 2.5 mm is needed.

"Failure to follow the above rules can turn proof to pretense," she said.

Common errors in Mohs surgery occur in planning the second stage, particularly inadequate overlap and lack of concern about observing the line of connection of stage II to stage I. "Undermining-type reexcisions in which the dermal rim of tissue is undermined and a vertical or beveled incision is made circumferentially around the defect connecting to this plane, frequently accompanied by vertical incision extending radially from the defect to complete this excision, [are] a common error," she said.

"This section is then processed so that only one of the four planes of the surgical margin is examined. The exclusion of the deep margin and the radially cut ends of the specimen from exam can allow tumor to be left behind. Proper process of an undermining stage II is difficult for the technician. Even if this type of reexcision is processed properly, there is inadequate overlap on the deep margin," she said.

"Straight-down cuts, such as the type made when stage II is reexcising half of the stage I defect, are another source of error," she said. "If a straight-down cut is used and not adequately flattened, this 2.5 mm of necessary overlap doubles the every-0.2 mm of space between the defect and the depth of the reexcision. This needed overlap can easily exceed the size of the defect."

SANTA ANA PUEBLO, N.M. — Evaluation of Mohs specimens sent to the American Society for Mohs Surgery for peer review has offered an opportunity to critique various styles of processing Mohs specimens and of planning second stages.

Some styles fail to comply with the basic principle of Mohs surgery. Undermining-type stage II reexcisions, straight-down cuts through the midline of stage II, and squared-off edges are examples of types of stage II reexcisions "that can turn the Mohs proof of tumor extirpation to pretense," Dr. Sharon F. Tiefenbrunn said at a meeting of the American Society for Mohs Surgery (ASMS).

Mohs surgery "is a proven technique with a 95%–99% cure rate in the published literature," she said, but the rules "used to plan reexcision and to evaluate adequacy of the slides from these reexcisions have not been published."

She discussed her "rules" for Mohs surgery based on patterns that emerged during the analysis. "Most of these rules are fairly obvious and are stated for completeness," said Dr. Tiefenbrunn, a dermatologic surgeon who practices in St. Louis and is the current president of the ASMS.

Rules for stage I include the following:

▸ The complete skin edge must be included on the slides and examined. (The ASMS uses 90% as its standard of completeness.)

▸ The complete deep margin (90%) must be present on the slide.

▸ Make sure tissue remains intact on the wafers, without shredding.

▸ Make sure structural details are visible.

▸ Use adequate stain.

▸ Use visible ink for orientation and to ensure complete examination of sectioned specimens.

▸ Tumor must be identified and mapped accurately.

The rules for stage II include:

▸ If the skin edge is missing on stage I, it must be taken on stage II.

▸ If deep tissue is missing on stage I, it must be taken on stage II. "We see a few cases where these simple mandates slide by," she said.

▸ Stage II must include the tumor in stage I. "Early wafers must be unequivocally clear to call the stage clear if tumor is seen deep in the block," she said.

▸ Respect the Heisenberg uncertainty principle. "We must overlap in all directions from the edge of the tumor and we must connect to the previous layer and confirm with inked margins," said Dr. Tiefenbrunn.

If the connection to the defect left by the previous stage is not examined, a larger overlap will be needed.

She pointed out that taking 20 turns of the cryostat before putting a section on the slide means that approximately 200 micrometers of tissue from the sample are lost. This amounts to 0.2 mm, a space in which tumor can travel undetected. If 95% of all possible angles of spread of the tumor are to be examined, an overlap of about 2.5 mm is needed.

"Failure to follow the above rules can turn proof to pretense," she said.

Common errors in Mohs surgery occur in planning the second stage, particularly inadequate overlap and lack of concern about observing the line of connection of stage II to stage I. "Undermining-type reexcisions in which the dermal rim of tissue is undermined and a vertical or beveled incision is made circumferentially around the defect connecting to this plane, frequently accompanied by vertical incision extending radially from the defect to complete this excision, [are] a common error," she said.

"This section is then processed so that only one of the four planes of the surgical margin is examined. The exclusion of the deep margin and the radially cut ends of the specimen from exam can allow tumor to be left behind. Proper process of an undermining stage II is difficult for the technician. Even if this type of reexcision is processed properly, there is inadequate overlap on the deep margin," she said.

"Straight-down cuts, such as the type made when stage II is reexcising half of the stage I defect, are another source of error," she said. "If a straight-down cut is used and not adequately flattened, this 2.5 mm of necessary overlap doubles the every-0.2 mm of space between the defect and the depth of the reexcision. This needed overlap can easily exceed the size of the defect."

Publications
Publications
Topics
Article Type
Display Headline
Expert's Mohs Tips Based on Review of Slides
Display Headline
Expert's Mohs Tips Based on Review of Slides
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Creative Muscular Flaps Fill in Deep Mohs Facial Defects

Article Type
Changed
Display Headline
Creative Muscular Flaps Fill in Deep Mohs Facial Defects

NAPLES, FLA. — Muscular flaps that supply soft tissue volume and a good vascular supply can provide some of the best cosmetic results in the reconstruction of Mohs surgery facial defects that penetrate to bone or cartilage, speakers said at the annual meeting of the American College of Mohs Surgery.

Muscular hinge flaps. These flaps are useful for replacing soft-tissue volume in deep defects that may extend to bone or cartilage and require coverage with a full-thickness skin graft for practical or functional reasons, said Dr. Neil J. Mortimer, a Mohs surgery fellow at the Skin Centre in Tauranga, New Zealand.

"These are generally defects where you'd want to choose a full-thickness skin graft repair over other reconstructive options," Dr. Mortimer pointed out.

Since reconstruction of the vermilion of the lower lip with a simple mucosal flap would leave a substantial loss of volume, Dr. Mortimer recommended the use of orbicularis oris hinge flaps. A flap from the underlying orbicularis muscle is dissected out laterally and is then turned back or hinged into the defect.

"We've found from experience that if the surgical defect is deeper than a millimeter or so, it's useful to dissect these flaps from both sides and overlap them in the defect," Dr. Mortimer said.

Deep defects on the nose can be reconstructed with flaps derived from the superficial nasalis musculoaponeurotic system without causing a functional compromise. The flap can be dissected by separating it from its superior and inferior attachments to work as a simple hinge. These flaps can be unilateral or bilateral.

Frontalis hinge flaps can resurface exposed bone on the forehead. Postauricular defects with exposed partial-thickness cartilage can be repaired with an auricularis posterior hinge flap, which carries a good vascular supply from the auricular branch of the posterior auricular artery, he said.

Galeal hinge flap. "This is a reconstruction that we found particularly useful for repairing defects of the scalp, extending to bone, as a single-stage procedure," said Dr. Matthew Halpern, a fellow in procedural dermatology at Columbia University, New York.

The galea aponeurotica is a strong, inelastic fibrous sheath situated between subcutaneous and loose areolar tissue that covers the calvaria and represents the tendinous connection between the frontalis muscle anteriorly and the occipitalis muscle posteriorly.

In constructing the flap, the galea is lightly scored so that it can be advanced and hinged over the top of the exposed periosteum. A galeal hinge flap is different from a muscular hinge flap because the galea is relatively inelastic, so defects often require bilateral flaps for coverage of the exposed bone. The galea also is thin and will not make an overall change in wound depth.

Dr. Halpern places full-thickness skin grafts on top of the galeal hinge flap to close the rest of the wound. He uses local anesthesia for the whole procedure.

Nasalis myocutaneous island pedicle flap. This flap can be used to repair defects that cover two anatomic units on the nose—the ala and sidewall—with the alar groove as an anatomic boundary line. It can be used in place of a full-thickness skin graft, an island pedicle flap from the side, or a medially based cheek-to-nose transposition flap, said Dr. Robert J. Willard, a Mohs surgery fellow at Brown University, Providence, R.I.

The flap is made superior to the defect, with wide undermining to provide mobility and avoid pin cushioning. The first key sutures are made by stitching the lateral and medial aspects of the leading edge of the flap anteriorly and posteriorly to the origin of the alar groove. The leading edge of the flap is aligned with the alar groove, which recreates the anatomic boundary. No sutures are placed at the inferior portion of the defect since this would create a vertical tension vector and risk alar elevation.

Placement of a guiding suture roughly parallel to the alar rim in the residual alar portion redirects the tension vector to avoid alar elevation while the residual alar defect heals by second intention, he said.

Article PDF
Author and Disclosure Information

Publications
Topics
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

NAPLES, FLA. — Muscular flaps that supply soft tissue volume and a good vascular supply can provide some of the best cosmetic results in the reconstruction of Mohs surgery facial defects that penetrate to bone or cartilage, speakers said at the annual meeting of the American College of Mohs Surgery.

Muscular hinge flaps. These flaps are useful for replacing soft-tissue volume in deep defects that may extend to bone or cartilage and require coverage with a full-thickness skin graft for practical or functional reasons, said Dr. Neil J. Mortimer, a Mohs surgery fellow at the Skin Centre in Tauranga, New Zealand.

"These are generally defects where you'd want to choose a full-thickness skin graft repair over other reconstructive options," Dr. Mortimer pointed out.

Since reconstruction of the vermilion of the lower lip with a simple mucosal flap would leave a substantial loss of volume, Dr. Mortimer recommended the use of orbicularis oris hinge flaps. A flap from the underlying orbicularis muscle is dissected out laterally and is then turned back or hinged into the defect.

"We've found from experience that if the surgical defect is deeper than a millimeter or so, it's useful to dissect these flaps from both sides and overlap them in the defect," Dr. Mortimer said.

Deep defects on the nose can be reconstructed with flaps derived from the superficial nasalis musculoaponeurotic system without causing a functional compromise. The flap can be dissected by separating it from its superior and inferior attachments to work as a simple hinge. These flaps can be unilateral or bilateral.

Frontalis hinge flaps can resurface exposed bone on the forehead. Postauricular defects with exposed partial-thickness cartilage can be repaired with an auricularis posterior hinge flap, which carries a good vascular supply from the auricular branch of the posterior auricular artery, he said.

Galeal hinge flap. "This is a reconstruction that we found particularly useful for repairing defects of the scalp, extending to bone, as a single-stage procedure," said Dr. Matthew Halpern, a fellow in procedural dermatology at Columbia University, New York.

The galea aponeurotica is a strong, inelastic fibrous sheath situated between subcutaneous and loose areolar tissue that covers the calvaria and represents the tendinous connection between the frontalis muscle anteriorly and the occipitalis muscle posteriorly.

In constructing the flap, the galea is lightly scored so that it can be advanced and hinged over the top of the exposed periosteum. A galeal hinge flap is different from a muscular hinge flap because the galea is relatively inelastic, so defects often require bilateral flaps for coverage of the exposed bone. The galea also is thin and will not make an overall change in wound depth.

Dr. Halpern places full-thickness skin grafts on top of the galeal hinge flap to close the rest of the wound. He uses local anesthesia for the whole procedure.

Nasalis myocutaneous island pedicle flap. This flap can be used to repair defects that cover two anatomic units on the nose—the ala and sidewall—with the alar groove as an anatomic boundary line. It can be used in place of a full-thickness skin graft, an island pedicle flap from the side, or a medially based cheek-to-nose transposition flap, said Dr. Robert J. Willard, a Mohs surgery fellow at Brown University, Providence, R.I.

The flap is made superior to the defect, with wide undermining to provide mobility and avoid pin cushioning. The first key sutures are made by stitching the lateral and medial aspects of the leading edge of the flap anteriorly and posteriorly to the origin of the alar groove. The leading edge of the flap is aligned with the alar groove, which recreates the anatomic boundary. No sutures are placed at the inferior portion of the defect since this would create a vertical tension vector and risk alar elevation.

Placement of a guiding suture roughly parallel to the alar rim in the residual alar portion redirects the tension vector to avoid alar elevation while the residual alar defect heals by second intention, he said.

NAPLES, FLA. — Muscular flaps that supply soft tissue volume and a good vascular supply can provide some of the best cosmetic results in the reconstruction of Mohs surgery facial defects that penetrate to bone or cartilage, speakers said at the annual meeting of the American College of Mohs Surgery.

Muscular hinge flaps. These flaps are useful for replacing soft-tissue volume in deep defects that may extend to bone or cartilage and require coverage with a full-thickness skin graft for practical or functional reasons, said Dr. Neil J. Mortimer, a Mohs surgery fellow at the Skin Centre in Tauranga, New Zealand.

"These are generally defects where you'd want to choose a full-thickness skin graft repair over other reconstructive options," Dr. Mortimer pointed out.

Since reconstruction of the vermilion of the lower lip with a simple mucosal flap would leave a substantial loss of volume, Dr. Mortimer recommended the use of orbicularis oris hinge flaps. A flap from the underlying orbicularis muscle is dissected out laterally and is then turned back or hinged into the defect.

"We've found from experience that if the surgical defect is deeper than a millimeter or so, it's useful to dissect these flaps from both sides and overlap them in the defect," Dr. Mortimer said.

Deep defects on the nose can be reconstructed with flaps derived from the superficial nasalis musculoaponeurotic system without causing a functional compromise. The flap can be dissected by separating it from its superior and inferior attachments to work as a simple hinge. These flaps can be unilateral or bilateral.

Frontalis hinge flaps can resurface exposed bone on the forehead. Postauricular defects with exposed partial-thickness cartilage can be repaired with an auricularis posterior hinge flap, which carries a good vascular supply from the auricular branch of the posterior auricular artery, he said.

Galeal hinge flap. "This is a reconstruction that we found particularly useful for repairing defects of the scalp, extending to bone, as a single-stage procedure," said Dr. Matthew Halpern, a fellow in procedural dermatology at Columbia University, New York.

The galea aponeurotica is a strong, inelastic fibrous sheath situated between subcutaneous and loose areolar tissue that covers the calvaria and represents the tendinous connection between the frontalis muscle anteriorly and the occipitalis muscle posteriorly.

In constructing the flap, the galea is lightly scored so that it can be advanced and hinged over the top of the exposed periosteum. A galeal hinge flap is different from a muscular hinge flap because the galea is relatively inelastic, so defects often require bilateral flaps for coverage of the exposed bone. The galea also is thin and will not make an overall change in wound depth.

Dr. Halpern places full-thickness skin grafts on top of the galeal hinge flap to close the rest of the wound. He uses local anesthesia for the whole procedure.

Nasalis myocutaneous island pedicle flap. This flap can be used to repair defects that cover two anatomic units on the nose—the ala and sidewall—with the alar groove as an anatomic boundary line. It can be used in place of a full-thickness skin graft, an island pedicle flap from the side, or a medially based cheek-to-nose transposition flap, said Dr. Robert J. Willard, a Mohs surgery fellow at Brown University, Providence, R.I.

The flap is made superior to the defect, with wide undermining to provide mobility and avoid pin cushioning. The first key sutures are made by stitching the lateral and medial aspects of the leading edge of the flap anteriorly and posteriorly to the origin of the alar groove. The leading edge of the flap is aligned with the alar groove, which recreates the anatomic boundary. No sutures are placed at the inferior portion of the defect since this would create a vertical tension vector and risk alar elevation.

Placement of a guiding suture roughly parallel to the alar rim in the residual alar portion redirects the tension vector to avoid alar elevation while the residual alar defect heals by second intention, he said.

Publications
Publications
Topics
Article Type
Display Headline
Creative Muscular Flaps Fill in Deep Mohs Facial Defects
Display Headline
Creative Muscular Flaps Fill in Deep Mohs Facial Defects
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

ROM Flap Successful for Medium-Sized Defects

Article Type
Changed
Display Headline
ROM Flap Successful for Medium-Sized Defects

SANTA ANA PUEBLO, N.M. — The reducing opposed multilobed flap repair offers significant advantages over traditional closure methods for medium-size skin cancer defects below the knee, especially with respect to flap necrosis and overall complications, Dr. Anthony J. Dixon said at a meeting of the American Society for Mohs Surgery.

The reducing opposed multilobed (ROM) technique, which Dr. Dixon developed and first described a few years ago, uses a random-pattern skin flap for defects below the knee that are 10–45 mm in diameter (Dermatol. Surg. 2004;30:1406–11). The pattern consists of semicircular lobes that extend both cephalically and caudally from the defect. The largest semicircle is two-thirds of the diameter of the primary defect.

"The next semicircle is two-thirds the diameter of the first semicircle and so on," said Dr. Dixon, a dermatologic surgeon who practices in Belmont, Australia. "You keep making semicircles until you have semicircles 5–8 mm in diameter; then you stop."

The number of semicircles depends on the depth of the primary lesion. "It's quite common to have three semicircles on each side [of the defect]," he said.

The technique involves transposing each semicircular lobe with standard sutures, starting from the lobes most distant from the defect and working inward.

"Throughout the technique you know that tension is being accumulated along the way," said Dr. Dixon, who also is director of research for Skin Alert Skin Cancer Clinics, a network of 13 clinics in Australia. "Rather than tension being in the central defect, tension is being accumulated at the periphery. Therefore, it should result in less wound tension and breakdown centrally."

Postoperatively, Dr. Dixon advises his patients to minimize walking for 24 hours and then slowly increase the amount of walking. "We ask them when they are seated to elevate their leg when they can for the first 4 days," he added.

He takes every alternate suture out in 2 weeks and the rest at 3 weeks. At 6 months, scarring from the procedure "is invariably difficult to find," he said.

In an unpublished analysis, Dr. Dixon and his associates compared 212 patients who underwent ROM flap repairs with 83 patients who underwent repair with ellipse or with other random flap patterns. The diameter of the defect size in all patients ranged from 11 to 45 mm.

The rate of partial flap necrosis was 0.9% in the ROM flap group, compared with 7.2% in the non-ROM flap group, a difference that was statistically significant. The overall rate of complications was 12.7% in the ROM flap group, compared with 28.9% in the non-ROM flap group, a difference that also was statistically significant, he reported.

There were no statistically significant differences between the two groups in terms of the rates of postoperative infections and wound dehiscence, although the rates were smaller in the ROM flap group than in the non-ROM flap group.

The patients "generally liked" the ROM flap procedure. "They liked being able to get up and walk around," Dr. Dixon said.

The study had several limitations: It was not randomized, it was a consecutive series of patients, and all the procedures were performed by Dr. Dixon. "A prospective, randomized controlled trial would be valuable to confirm the findings of this retrospective study," he said.

The reducing opposed multilobed (ROM) flap repair is used for defects below the knee.

Semicircular lobes extend cephalically and caudally from the defect. The largest semicircle is two-thirds of the diameter of the primary defect.

Each of the lobes is transposed with standard sutures, starting from the lobes most distant from the defect and from working inward.

Suturing is finished. Every alternate suture will be taken out in 2 weeks, and the rest at 3 weeks. Photos courtesy Dr. Anthony J. Dixon

Article PDF
Author and Disclosure Information

Publications
Topics
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

SANTA ANA PUEBLO, N.M. — The reducing opposed multilobed flap repair offers significant advantages over traditional closure methods for medium-size skin cancer defects below the knee, especially with respect to flap necrosis and overall complications, Dr. Anthony J. Dixon said at a meeting of the American Society for Mohs Surgery.

The reducing opposed multilobed (ROM) technique, which Dr. Dixon developed and first described a few years ago, uses a random-pattern skin flap for defects below the knee that are 10–45 mm in diameter (Dermatol. Surg. 2004;30:1406–11). The pattern consists of semicircular lobes that extend both cephalically and caudally from the defect. The largest semicircle is two-thirds of the diameter of the primary defect.

"The next semicircle is two-thirds the diameter of the first semicircle and so on," said Dr. Dixon, a dermatologic surgeon who practices in Belmont, Australia. "You keep making semicircles until you have semicircles 5–8 mm in diameter; then you stop."

The number of semicircles depends on the depth of the primary lesion. "It's quite common to have three semicircles on each side [of the defect]," he said.

The technique involves transposing each semicircular lobe with standard sutures, starting from the lobes most distant from the defect and working inward.

"Throughout the technique you know that tension is being accumulated along the way," said Dr. Dixon, who also is director of research for Skin Alert Skin Cancer Clinics, a network of 13 clinics in Australia. "Rather than tension being in the central defect, tension is being accumulated at the periphery. Therefore, it should result in less wound tension and breakdown centrally."

Postoperatively, Dr. Dixon advises his patients to minimize walking for 24 hours and then slowly increase the amount of walking. "We ask them when they are seated to elevate their leg when they can for the first 4 days," he added.

He takes every alternate suture out in 2 weeks and the rest at 3 weeks. At 6 months, scarring from the procedure "is invariably difficult to find," he said.

In an unpublished analysis, Dr. Dixon and his associates compared 212 patients who underwent ROM flap repairs with 83 patients who underwent repair with ellipse or with other random flap patterns. The diameter of the defect size in all patients ranged from 11 to 45 mm.

The rate of partial flap necrosis was 0.9% in the ROM flap group, compared with 7.2% in the non-ROM flap group, a difference that was statistically significant. The overall rate of complications was 12.7% in the ROM flap group, compared with 28.9% in the non-ROM flap group, a difference that also was statistically significant, he reported.

There were no statistically significant differences between the two groups in terms of the rates of postoperative infections and wound dehiscence, although the rates were smaller in the ROM flap group than in the non-ROM flap group.

The patients "generally liked" the ROM flap procedure. "They liked being able to get up and walk around," Dr. Dixon said.

The study had several limitations: It was not randomized, it was a consecutive series of patients, and all the procedures were performed by Dr. Dixon. "A prospective, randomized controlled trial would be valuable to confirm the findings of this retrospective study," he said.

The reducing opposed multilobed (ROM) flap repair is used for defects below the knee.

Semicircular lobes extend cephalically and caudally from the defect. The largest semicircle is two-thirds of the diameter of the primary defect.

Each of the lobes is transposed with standard sutures, starting from the lobes most distant from the defect and from working inward.

Suturing is finished. Every alternate suture will be taken out in 2 weeks, and the rest at 3 weeks. Photos courtesy Dr. Anthony J. Dixon

SANTA ANA PUEBLO, N.M. — The reducing opposed multilobed flap repair offers significant advantages over traditional closure methods for medium-size skin cancer defects below the knee, especially with respect to flap necrosis and overall complications, Dr. Anthony J. Dixon said at a meeting of the American Society for Mohs Surgery.

The reducing opposed multilobed (ROM) technique, which Dr. Dixon developed and first described a few years ago, uses a random-pattern skin flap for defects below the knee that are 10–45 mm in diameter (Dermatol. Surg. 2004;30:1406–11). The pattern consists of semicircular lobes that extend both cephalically and caudally from the defect. The largest semicircle is two-thirds of the diameter of the primary defect.

"The next semicircle is two-thirds the diameter of the first semicircle and so on," said Dr. Dixon, a dermatologic surgeon who practices in Belmont, Australia. "You keep making semicircles until you have semicircles 5–8 mm in diameter; then you stop."

The number of semicircles depends on the depth of the primary lesion. "It's quite common to have three semicircles on each side [of the defect]," he said.

The technique involves transposing each semicircular lobe with standard sutures, starting from the lobes most distant from the defect and working inward.

"Throughout the technique you know that tension is being accumulated along the way," said Dr. Dixon, who also is director of research for Skin Alert Skin Cancer Clinics, a network of 13 clinics in Australia. "Rather than tension being in the central defect, tension is being accumulated at the periphery. Therefore, it should result in less wound tension and breakdown centrally."

Postoperatively, Dr. Dixon advises his patients to minimize walking for 24 hours and then slowly increase the amount of walking. "We ask them when they are seated to elevate their leg when they can for the first 4 days," he added.

He takes every alternate suture out in 2 weeks and the rest at 3 weeks. At 6 months, scarring from the procedure "is invariably difficult to find," he said.

In an unpublished analysis, Dr. Dixon and his associates compared 212 patients who underwent ROM flap repairs with 83 patients who underwent repair with ellipse or with other random flap patterns. The diameter of the defect size in all patients ranged from 11 to 45 mm.

The rate of partial flap necrosis was 0.9% in the ROM flap group, compared with 7.2% in the non-ROM flap group, a difference that was statistically significant. The overall rate of complications was 12.7% in the ROM flap group, compared with 28.9% in the non-ROM flap group, a difference that also was statistically significant, he reported.

There were no statistically significant differences between the two groups in terms of the rates of postoperative infections and wound dehiscence, although the rates were smaller in the ROM flap group than in the non-ROM flap group.

The patients "generally liked" the ROM flap procedure. "They liked being able to get up and walk around," Dr. Dixon said.

The study had several limitations: It was not randomized, it was a consecutive series of patients, and all the procedures were performed by Dr. Dixon. "A prospective, randomized controlled trial would be valuable to confirm the findings of this retrospective study," he said.

The reducing opposed multilobed (ROM) flap repair is used for defects below the knee.

Semicircular lobes extend cephalically and caudally from the defect. The largest semicircle is two-thirds of the diameter of the primary defect.

Each of the lobes is transposed with standard sutures, starting from the lobes most distant from the defect and from working inward.

Suturing is finished. Every alternate suture will be taken out in 2 weeks, and the rest at 3 weeks. Photos courtesy Dr. Anthony J. Dixon

Publications
Publications
Topics
Article Type
Display Headline
ROM Flap Successful for Medium-Sized Defects
Display Headline
ROM Flap Successful for Medium-Sized Defects
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Understanding Injectable Poly-L-lactic Acid

Article Type
Changed
Display Headline
Understanding Injectable Poly-L-lactic Acid

Article PDF
Author and Disclosure Information

Butterwick K

Issue
Cutis - 79(06)
Publications
Topics
Page Number
388-392
Sections
Author and Disclosure Information

Butterwick K

Author and Disclosure Information

Butterwick K

Article PDF
Article PDF

Issue
Cutis - 79(06)
Issue
Cutis - 79(06)
Page Number
388-392
Page Number
388-392
Publications
Publications
Topics
Article Type
Display Headline
Understanding Injectable Poly-L-lactic Acid
Display Headline
Understanding Injectable Poly-L-lactic Acid
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Evaluation of Mineral Cosmetics

Article Type
Changed
Display Headline
Evaluation of Mineral Cosmetics

Article PDF
Author and Disclosure Information

Saluja R, Yosowitz G, Goldman MP

Issue
Cutis - 79(06)
Publications
Topics
Page Number
382-387
Sections
Author and Disclosure Information

Saluja R, Yosowitz G, Goldman MP

Author and Disclosure Information

Saluja R, Yosowitz G, Goldman MP

Article PDF
Article PDF

Issue
Cutis - 79(06)
Issue
Cutis - 79(06)
Page Number
382-387
Page Number
382-387
Publications
Publications
Topics
Article Type
Display Headline
Evaluation of Mineral Cosmetics
Display Headline
Evaluation of Mineral Cosmetics
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Efficacy and Tolerability of Once-Daily 5-Fluorouracil 5% Cream for Treatment of Actinic Keratoses

Article Type
Changed
Display Headline
Efficacy and Tolerability of Once-Daily 5-Fluorouracil 5% Cream for Treatment of Actinic Keratoses

Article PDF
Author and Disclosure Information

Woodson JM

Issue
Cutis - 79(06)
Publications
Topics
Page Number
378-381
Sections
Author and Disclosure Information

Woodson JM

Author and Disclosure Information

Woodson JM

Article PDF
Article PDF

Issue
Cutis - 79(06)
Issue
Cutis - 79(06)
Page Number
378-381
Page Number
378-381
Publications
Publications
Topics
Article Type
Display Headline
Efficacy and Tolerability of Once-Daily 5-Fluorouracil 5% Cream for Treatment of Actinic Keratoses
Display Headline
Efficacy and Tolerability of Once-Daily 5-Fluorouracil 5% Cream for Treatment of Actinic Keratoses
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

LipoLite&#174 Program Combines the VelaSmooth&#8482 Contour Applicator With Injections to Optimize Fat Reduction

Article Type
Changed
Display Headline
LipoLite&#174 Program Combines the VelaSmooth&#8482 Contour Applicator With Injections to Optimize Fat Reduction

Article PDF
Author and Disclosure Information

Mulholland RS

Issue
Cutis - 79(06)
Publications
Topics
Page Number
374-375
Sections
Author and Disclosure Information

Mulholland RS

Author and Disclosure Information

Mulholland RS

Article PDF
Article PDF

Issue
Cutis - 79(06)
Issue
Cutis - 79(06)
Page Number
374-375
Page Number
374-375
Publications
Publications
Topics
Article Type
Display Headline
LipoLite&#174 Program Combines the VelaSmooth&#8482 Contour Applicator With Injections to Optimize Fat Reduction
Display Headline
LipoLite&#174 Program Combines the VelaSmooth&#8482 Contour Applicator With Injections to Optimize Fat Reduction
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Open Study Comparing Sodium L-Ascorbyl-2-Phosphate 5% Lotion Versus Adapalene 0.1% Gel for Acne Vulgaris

Article Type
Changed
Display Headline
Open Study Comparing Sodium L-Ascorbyl-2-Phosphate 5% Lotion Versus Adapalene 0.1% Gel for Acne Vulgaris

Article PDF
Author and Disclosure Information

Ikeno H, Ohmori K

Issue
Cutis - 79(06)
Publications
Topics
Page Number
368-372
Sections
Author and Disclosure Information

Ikeno H, Ohmori K

Author and Disclosure Information

Ikeno H, Ohmori K

Article PDF
Article PDF

Issue
Cutis - 79(06)
Issue
Cutis - 79(06)
Page Number
368-372
Page Number
368-372
Publications
Publications
Topics
Article Type
Display Headline
Open Study Comparing Sodium L-Ascorbyl-2-Phosphate 5% Lotion Versus Adapalene 0.1% Gel for Acne Vulgaris
Display Headline
Open Study Comparing Sodium L-Ascorbyl-2-Phosphate 5% Lotion Versus Adapalene 0.1% Gel for Acne Vulgaris
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Barriers to UV Radiation Lip Protection

Article Type
Changed
Display Headline
Barriers to UV Radiation Lip Protection

Article PDF
Author and Disclosure Information

Dimmick JR, Uchida T, Wagner RF Jr

Issue
Cutis - 79(06)
Publications
Topics
Page Number
363-366
Sections
Author and Disclosure Information

Dimmick JR, Uchida T, Wagner RF Jr

Author and Disclosure Information

Dimmick JR, Uchida T, Wagner RF Jr

Article PDF
Article PDF

Issue
Cutis - 79(06)
Issue
Cutis - 79(06)
Page Number
363-366
Page Number
363-366
Publications
Publications
Topics
Article Type
Display Headline
Barriers to UV Radiation Lip Protection
Display Headline
Barriers to UV Radiation Lip Protection
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Do Cosmeceutical Agents Combined With Pharmeceutical Agents Improve Therapeutics?

Article Type
Changed
Display Headline
Do Cosmeceutical Agents Combined With Pharmeceutical Agents Improve Therapeutics?

Article PDF
Author and Disclosure Information

Draelos ZD

Issue
Cutis - 79(06)
Publications
Topics
Page Number
356-358
Sections
Author and Disclosure Information

Draelos ZD

Author and Disclosure Information

Draelos ZD

Article PDF
Article PDF

Issue
Cutis - 79(06)
Issue
Cutis - 79(06)
Page Number
356-358
Page Number
356-358
Publications
Publications
Topics
Article Type
Display Headline
Do Cosmeceutical Agents Combined With Pharmeceutical Agents Improve Therapeutics?
Display Headline
Do Cosmeceutical Agents Combined With Pharmeceutical Agents Improve Therapeutics?
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media